Related Experiment Video
Updated: May 6, 2026

11:01
Imaging-Guided Bioreactor for Generating Bioengineered Airway Tissue
Published on: April 6, 2022
2.2K
Tissue engineering airway mucosa: a systematic review.
Nicholas Hamilton1, Anthony J Bullock, Sheila Macneil
1University College London Ear Institute, Sheffield, United Kingdom.
The Laryngoscope
|October 17, 2013
Summary
Tissue engineering shows promise for airway mucosa regeneration, but challenges remain in mucosalization. Future research should focus on epithelial tracking and the extracellular environment for improved therapeutic potential.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Tissue Engineering
Background:
- Current treatments for hollow organ conditions like stenosis are inadequate.
- Tissue-engineered implants offer a potential solution but face challenges with mucosalization post-transplantation.
- Regenerating airway mucosa is crucial for protecting against infection and facilitating healing.
Purpose of the Study:
- To systematically review literature on tissue-engineered airway mucosa.
- To assess the success and potential applications of this technology in airway regenerative medicine.
- To identify future research directions for therapeutic and commercial advancement.
Main Methods:
- Systematic literature review of Medline and Embase databases.
- Included original studies on airway mucosal regeneration in animal models and humans.
- Search terms focused on "tissue engineering" and "mucosa" or "mucous membrane."
Main Results:
- Seventeen studies met inclusion criteria, with 13 in animal models and 4 in humans.
- An intact mucosal layer is vital for infection protection; fibroblasts may aid epithelial regeneration.
- Various scaffold materials were used, with no single material demonstrating clear superiority.
Conclusions:
- Significant gaps exist in the current literature on tissue-engineered airway mucosa.
- Future research should prioritize epithelial tracking and understanding the extracellular environment's role.
- Optimizing these areas is key to maximizing the therapeutic and commercial potential of airway regenerative medicine.

